Treatment Options for Muscle-invasive Urothelial Cancer for Patients Who Were Not Eligible for Cystectomy or Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin: Report of Southwest Oncology Group Trial 8733

BACKGROUND. Many patients with invasive urothelial cell cancer are poor candidates for cisplatin-based chemotherapy, and many are high risk for cystectomy. Southwest Oncology Group Trial 8733 was designed to address treatment for such patients. METHODS. Eligible patients had primary or recurrent mus...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer
Autori principali: Higano, Celestia S., Tangen, Catherine M., Sakr, Wael A., Faulkner, James, Rivkin, Saul E., Meyers, Frederick J., Hussain, Maha, Baker, Laurence H., Russell, Kenneth J., Crawford, E. David
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8211356/
https://ncbi.nlm.nih.gov/pubmed/18404692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23420
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi